Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8651
Arbutus Biopharma
ABUS
$915M
| $351K | ﹤0.01% |
98,897
+28,731
| +41% | +$101K |
|
|
PPBI
8652
DELISTED
Pacific Premier Bancorp
PPBI
| $351K | ﹤0.01% |
+11,217
| New | +$311K |
|
8653
PUT
ProShares UltraShort QQQ
QID
$247M
| $351K | ﹤0.01% |
2,470
-1,565
| -39% | -$260K |
|
8654
PUT
XPEL
XPEL
$1.38B
| $351K | ﹤0.01% |
6,800
-4,000
| -37% | -$145K |
|
|
WIRE
8655
CALL
DELISTED
Encore Wire Corp
WIRE
| $351K | ﹤0.01% |
5,800
-10,500
| -64% | -$543K |
|
|
NBEV
8656
PUT
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $351K | ﹤0.01% |
133,300
-7,600
| -5% | -$20.6K |
|
8657
Global X Aging Population ETF
AGNG
$89.1M
| $350K | ﹤0.01% |
+12,494
| New | +$332K |
|
|
ALEX
8658
CALL
DELISTED
Alexander & Baldwin
ALEX
| $350K | ﹤0.01% |
20,400
-500
| -2% | -$7.3K |
|
8659
Altisource Portfolio Solutions
ASPS
$65.8M
| $350K | ﹤0.01% |
3,400
-608
| -15% | -$62.7K |
|
8660
Cartesian Therapeutics
RNAC
$268M
| $350K | ﹤0.01% |
3,846
+3,277
| +576% | +$284K |
|
|
IBTB
8661
DELISTED
iShares iBonds Dec 2022 Term Treasury ETF
IBTB
| $350K | ﹤0.01% |
13,769
-18,121
| -57% | -$462K |
|
|
JOBS
8662
CALL
DELISTED
51job Inc
JOBS
| $350K | ﹤0.01% |
5,000
-3,500
| -41% | -$253K |
|
8663
PUT
QuinStreet
QNST
$1.21B
| $349K | ﹤0.01% |
+16,300
| New | +$297K |
|
8664
PUT
E.W. Scripps
SSP
$304M
| $349K | ﹤0.01% |
22,800
-13,700
| -38% | -$169K |
|
|
HMHC
8665
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $349K | ﹤0.01% |
105,011
+78,289
| +293% | +$233K |
|
|
SLT
8666
DELISTED
Pacer Salt High truBeta US Market ETF
SLT
| $349K | ﹤0.01% |
9,642
-6,902
| -42% | -$226K |
|
|
PPD
8667
PUT
DELISTED
PPD, Inc. Common Stock
PPD
| $349K | ﹤0.01% |
10,200
+3,100
| +44% | +$108K |
|
|
VER
8668
CALL
DELISTED
VEREIT, Inc.
VER
| $349K | ﹤0.01% |
9,240
-1,060
| -10% | -$37.6K |
|
8669
PUT
Costamare
CMRE
$1.77B
| $348K | ﹤0.01% |
42,000
-100
| -0.2% | -$697 |
|
8670
Cue Biopharma
CUE
$114M
| $348K | ﹤0.01% |
928
-6,320
| -87% | -$2.53M |
|
8671
Genesco
GCO
$422M
| $348K | ﹤0.01% |
11,550
-15,452
| -57% | -$395K |
|
8672
PUT
Pennant Group
PNTG
$1.36B
| $348K | ﹤0.01% |
+6,000
| New | +$289K |
|
8673
Quanta Services
PWR
$101B
| $348K | ﹤0.01% |
4,825
-542,841
| -99% | -$35.8M |
|
8674
PUT
Timken Company
TKR
$9.03B
| $348K | ﹤0.01% |
4,500
+400
| +10% | +$27.2K |
|
|
APTX
8675
DELISTED
Aptinyx Inc. Common Stock
APTX
| $348K | ﹤0.01% |
+100,636
| New | +$351K |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.